Showing 1 - 5 results of 5 for search 'Ginés Luengo-Gil', query time: 0.04s Refine Results
  1. 1
    A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

    A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant brea... by Esmeralda García-Torralba, Esmeralda García-Torralba, Esmeralda García-Torralba, Esther Navarro Manzano, Esther Navarro Manzano, Gines Luengo-Gil, Gines Luengo-Gil, Gines Luengo-Gil, Pilar De la Morena Barrio, Pilar De la Morena Barrio, Pilar De la Morena Barrio, Asunción Chaves Benito, Miguel Pérez-Ramos, Beatriz Álvarez-Abril, Beatriz Álvarez-Abril, Beatriz Álvarez-Abril, Alejandra Ivars Rubio, Alejandra Ivars Rubio, Alejandra Ivars Rubio, Elisa García-Garre, Elisa García-Garre, Elisa García-Garre, Francisco Ayala de la Peña, Francisco Ayala de la Peña, Francisco Ayala de la Peña, Elena García-Martínez, Elena García-Martínez, Elena García-Martínez, Elena García-Martínez

    Published 2023-05-01
    Get full text
    Article
  2. 2
    Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells

    Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells by Julia Peñas-Martínez, Ginés Luengo-Gil, Salvador Espín, Nataliya Bohdan, Carmen Ortega-Sabater, Maria Carmen Ródenas, David Zaragoza-Huesca, María José López-Andreo, Carme Plasencia, Vicente Vicente, Alberto Carmona-Bayonas, Irene Martínez-Martínez

    Published 2021-05-01
    Get full text
    Article
  3. 3
    PB2382: EFFECTS OF ANTIFASCIN COMPOUNDS AGAINST LYMPHOMA CELLS IN VITRO

    PB2382: EFFECTS OF ANTIFASCIN COMPOUNDS AGAINST LYMPHOMA CELLS IN VITRO by Ana María Hurtado López, Daniel Chedas, María José Sánchez de Las Matas Garre, Fátima Postigo-Corrales, Ana Albaladejo González, Asunción Beltrán Videla, Daniel Torres-Moreno, Ana Belén Arroyo-Rodríguez, José García-Solano, Pablo Conesa-Zamora, Gines Luengo-Gil

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry

    Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry by David Zaragoza-Huesca, Pedro Garrido-Rodríguez, Paula Jiménez-Fonseca, Eva Martínez de Castro, Manuel Sánchez-Cánovas, Laura Visa, Ana Custodio, Ana Fernández-Montes, Julia Peñas-Martínez, Patricia Morales del Burgo, Javier Gallego, Ginés Luengo-Gil, Vicente Vicente, Irene Martínez-Martínez, Alberto Carmona-Bayonas

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells by Maria Carmen Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, David Zaragoza-Huesca, Carmen Ortega-Sabater, Jorge Peña-García, Salvador Espín, Guillermo Ricote, Sofía Montenegro, Francisco Ayala-De La Peña, Ginés Luengo-Gil, Andrés Nieto, Francisco García-Molina, Vicente Vicente, Francesco Bernardi, María Luisa Lozano, Victoriano Mulero, Horacio Pérez-Sánchez, Alberto Carmona-Bayonas, Irene Martínez-Martínez

    Published 2023-05-01
    Get full text
    Article

Search Tools: